Home > Insider Trading > Filing (0000313143-10-000030)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
313143	Haemonetics Corp	HAE	Surgical & Medical Instruments & Apparatus (3841)	042882273

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1240941	J Joseph Forish	400 Wood Road Braintree MA 02184	Vp, Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-04-30	422	$45.70	4,559	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Non-Qualified Stock Option (right to buy)	$48.20	2006-12-19	2012-12-19	75,000	75,000	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$51.07	2008-10-24	2014-10-24	11,799	11,799	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$52.76	2007-05-05	2013-05-05	10,373	10,373	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$52.94	2010-10-27	2016-10-27	14,690	14,690	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$54.55	2009-10-22	2015-10-22	11,911	11,911	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2012-12-19	75,000	75,000	Direct
2014-10-24	11,799	11,799	Direct
2013-05-05	10,373	10,373	Direct
2016-10-27	14,690	14,690	Direct
2015-10-22	11,911	11,911	Direct

Footnotes

Acquisition of shares of Common Stock pursuant to the Employee Stock Purchase Plan. Participant elected to purchase shares at least six months in advance of the effective date of the transaction.
Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.